One possible explanation of how 2-AG could modulate the chemotaxis to CXCL12 is to impair the ability of the CXCR4 receptor to internalize and signal upon CXCL12 binding, as described in breast and prostate cancer [37]. Here, CXCL12 is linked to prostate cancer.